PYGO2 as a tumor marker in low-grade renal cell carcinoma
Abstract Background Renal cell carcinoma (RCC) is considered as one of the main causes of urological cancer-related mortalities globally. Early stage diagnosis can improve prognosis among RCC patients. However, a noticeable rate of RCC cases are diagnosed in advanced tumor stage due to the typical c...
Збережено в:
| Автори: | , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
SpringerOpen
2025-04-01
|
| Серія: | Egyptian Journal of Medical Human Genetics |
| Предмети: | |
| Онлайн доступ: | https://doi.org/10.1186/s43042-025-00707-6 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|
